Lifecome Biochemistry Co Ltd (002868) - Cash Flow Conversion Efficiency

Latest as of December 2025: -1.734x

Based on the latest financial reports, Lifecome Biochemistry Co Ltd (002868) has a cash flow conversion efficiency ratio of -1.734x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-112.57 Million ≈ $-16.47 Million USD) by net assets (CN¥64.93 Million ≈ $9.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002868 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Lifecome Biochemistry Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Lifecome Biochemistry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Lifecome Biochemistry Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lifecome Biochemistry Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Beijing Tongyizhong New Material Technology Corp SHG:688722	0.020x
Regulus Therapeutics Inc NASDAQ:RGLS	-0.154x
Zhejiang Risun Intelligent Technology Co. Ltd. A SHG:688215	N/A
Stendörren Fastigheter AB (publ) ST:STEF-B	0.020x
Shandong Lubei Chemical Co Ltd SHG:600727	0.017x
Beijing Trust Far Tech SHE:300231	0.091x
ForFarmers NV AS:FFARM	0.194x
Insteel Industries Inc NYSE:IIIN	-0.002x

Annual Cash Flow Conversion Efficiency for Lifecome Biochemistry Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Lifecome Biochemistry Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 002868 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥64.93 Million ≈ $9.50 Million	CN¥-25.08 Million ≈ $-3.67 Million	-0.386x	+93.30%
2024-12-31	CN¥-24.54 Million ≈ $-3.59 Million	CN¥141.41 Million ≈ $20.69 Million	-5.763x	-1177.91%
2023-12-31	CN¥414.11 Million ≈ $60.60 Million	CN¥-186.76 Million ≈ $-27.33 Million	-0.451x	-2959.86%
2022-12-31	CN¥599.30 Million ≈ $87.70 Million	CN¥-8.83 Million ≈ $-1.29 Million	-0.015x	-130.26%
2021-12-31	CN¥722.02 Million ≈ $105.65 Million	CN¥35.17 Million ≈ $5.15 Million	0.049x	-58.66%
2020-12-31	CN¥769.94 Million ≈ $112.67 Million	CN¥90.72 Million ≈ $13.28 Million	0.118x	+23.81%
2019-12-31	CN¥778.50 Million ≈ $113.92 Million	CN¥74.09 Million ≈ $10.84 Million	0.095x	-15.82%
2018-12-31	CN¥740.37 Million ≈ $108.34 Million	CN¥83.70 Million ≈ $12.25 Million	0.113x	-18.17%
2017-12-31	CN¥695.68 Million ≈ $101.80 Million	CN¥96.11 Million ≈ $14.06 Million	0.138x	-72.32%
2016-12-31	CN¥271.34 Million ≈ $39.71 Million	CN¥135.41 Million ≈ $19.81 Million	0.499x	-6.18%
2015-12-31	CN¥238.98 Million ≈ $34.97 Million	CN¥127.11 Million ≈ $18.60 Million	0.532x	+61.76%
2014-12-31	CN¥190.87 Million ≈ $27.93 Million	CN¥62.76 Million ≈ $9.18 Million	0.329x	-28.29%
2013-12-31	CN¥169.42 Million ≈ $24.79 Million	CN¥77.68 Million ≈ $11.37 Million	0.458x	+17.76%
2012-12-31	CN¥156.45 Million ≈ $22.89 Million	CN¥60.92 Million ≈ $8.91 Million	0.389x	--

About Lifecome Biochemistry Co Ltd

SHE:002868 China Biotechnology

Market Cap

$564.69 Million

CN¥3.86 Billion CNY

Market Cap Rank

#11763 Global

#3394 in China

Share Price

CN¥24.83

Change (1 day)

-2.63%

52-Week Range

CN¥22.08 - CN¥46.40

All Time High

CN¥61.57